Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J G Liese

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Lancet (London, England)|January 27, 1996
Chronic granulomatous disease in adultsJ G Liese, V Jendrossek, A Jansson, et al.
European Journal of Dermatology : EJD|March 22, 2000
Lupus erythematosus tumidus and chronic discoid lupus erythematosus in carriers of X-linked chronic granulomatous diseaseR A Rupec, T Petropoulou, B H Belohradsky, et al.
The Pediatric Infectious Disease Journal|July 6, 2000
Immunogenicity and safety of a trivalent tetanus, low dose diphtheria, inactivated poliomyelitis booster compared with a standard tetanus, low dose diphtheria booster at six to nine years of age. Munich Vaccine Study GroupS Stojanov, J G Liese, H Bendjenana, et al.
The Pediatric Infectious Disease Journal|October 20, 2001
Safety and immunogenicity of Biken acellular pertussis vaccine in combination with diphtheria and tetanus toxoid as a fifth dose at four to six years of age. Munich Vaccine Study GroupJ G Liese, S Stojanov, T H Zink, et al.
Vaccine|November 19, 2019
Increase in Streptococcus pneumoniae serotype 3 associated parapneumonic pleural effusion/empyema after the introduction of PCV13 in GermanyD Goettler, A Streng, D Kemmling, et al.
Vaccine|October 24, 2001
Large scale safety study of a liquid hexavalent vaccine (D-T-acP-IPV-PRP--T-HBs) administered at 2, 4, 6 and 12-14 months of ageJ G Liese, S Stojanov, F Berut, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 6, 2018
Changes in the incidence and bacterial aetiology of paediatric parapneumonic pleural effusions/empyema in Germany, 2010-2017: a nationwide surveillance studyJ G Liese, C Schoen, M van der Linden, et al.
The Pediatric Infectious Disease Journal|December 31, 1997
Efficacy of a two-component acellular pertussis vaccine in infantsJ G Liese, C K Meschievitz, E Harzer, et al.
Vaccine|October 2, 2007
Administration of hepatitis A vaccine at 6 and 12 months of age concomitantly with hexavalent (DTaP-IPV-PRP approximately T-HBs) combination vaccineS Stojanov, J G Liese, B H Belohradsky, et al.
Epidemiology and Infection|October 11, 2014
Incidence and clinical presentation of acute otitis media in children aged <6 years in European medical practices--ERRATUMJ G Liese, S A Silfverdal, C Giaquinto, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Lancet (London, England)|January 27, 1996
Chronic granulomatous disease in adultsJ G Liese, V Jendrossek, A Jansson, et al.
European Journal of Dermatology : EJD|March 22, 2000
Lupus erythematosus tumidus and chronic discoid lupus erythematosus in carriers of X-linked chronic granulomatous diseaseR A Rupec, T Petropoulou, B H Belohradsky, et al.
The Pediatric Infectious Disease Journal|July 6, 2000
Immunogenicity and safety of a trivalent tetanus, low dose diphtheria, inactivated poliomyelitis booster compared with a standard tetanus, low dose diphtheria booster at six to nine years of age. Munich Vaccine Study GroupS Stojanov, J G Liese, H Bendjenana, et al.
The Pediatric Infectious Disease Journal|October 20, 2001
Safety and immunogenicity of Biken acellular pertussis vaccine in combination with diphtheria and tetanus toxoid as a fifth dose at four to six years of age. Munich Vaccine Study GroupJ G Liese, S Stojanov, T H Zink, et al.
Vaccine|November 19, 2019
Increase in Streptococcus pneumoniae serotype 3 associated parapneumonic pleural effusion/empyema after the introduction of PCV13 in GermanyD Goettler, A Streng, D Kemmling, et al.
Vaccine|October 24, 2001
Large scale safety study of a liquid hexavalent vaccine (D-T-acP-IPV-PRP--T-HBs) administered at 2, 4, 6 and 12-14 months of ageJ G Liese, S Stojanov, F Berut, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 6, 2018
Changes in the incidence and bacterial aetiology of paediatric parapneumonic pleural effusions/empyema in Germany, 2010-2017: a nationwide surveillance studyJ G Liese, C Schoen, M van der Linden, et al.
The Pediatric Infectious Disease Journal|December 31, 1997
Efficacy of a two-component acellular pertussis vaccine in infantsJ G Liese, C K Meschievitz, E Harzer, et al.
Vaccine|October 2, 2007
Administration of hepatitis A vaccine at 6 and 12 months of age concomitantly with hexavalent (DTaP-IPV-PRP approximately T-HBs) combination vaccineS Stojanov, J G Liese, B H Belohradsky, et al.
Epidemiology and Infection|October 11, 2014
Incidence and clinical presentation of acute otitis media in children aged <6 years in European medical practices--ERRATUMJ G Liese, S A Silfverdal, C Giaquinto, et al.
Pageof 3